Company: Life Technologies, Carlsbad, CA
Entry Submitted By: Porter Novelli Life Sciences
Company Description: Life Technologies is a global biotechnology tools company dedicated to improving the human condition. The company has historical sales of approximately $3.5 billion, employs 9,500 people, has a presence in over 100 countries, and has a rapidly growing IP estate of over 3,600 patents and licenses. Life Technologies was created by the merger of Invitrogen Corporation and Applied Biosystems Inc.
Nomination Category: Company / Organization Categories
Nomination Sub Category: Tech Innovation of the Year
Nomination Title: Life Technologies
Tell the story about this nominated achievement since January 1 2011 (up to 500 words). Focus on specific accomplishments, and relate these accomplishments to past performance or industry norms. Be sure to mention obstacles overcome, innovations or discoveries made, and outcomes:
Life Technologies' brands are found in nearly every life sciences lab in the world and include innovative instrument systems under the Applied Biosystems and Ion Torrent names, as well as, its Invitrogen, GIBCO, Ambion, Molecular Probes and TaqMan products.
Life Technologies' introduced hundreds of new products in 2011, but none with as much potential to improve the human condition as the game-changing Ion Torrent semiconductor sequencing technology. This new method of genetic sequencing offers speed, simplicity, and scalability, and is applicable to scientists involved in every stage of discovery research.
• “Facing an immediate threat to human lives spotlights the profound power of science and collaboration. In 2011, when a deadly strain of E. coli quickly spread throughout Europe, the best scientific minds around the world came together to contain it. Armed with breakthrough semiconductor sequencing technology, research teams in China and Germany sequenced the hybrid bacterial strain in an unprecedented three hours. Had the outbreak occurred only months before, prior to the launch of the Ion PGM™ Sequencer, the process could have taken weeks, leaving millions of people exposed.” “Knowing the bacterium’s origin enabled Life Technologies scientists to quickly develop a PCR-based TaqMan® kit to test for it. In record time, health officials had the means to detect the strain in food samples. It was just a glimpse of how accelerated discovery can improve life”.
In less than a year since Life Technologies commercially launched the PGM™,the instrument has become the best-selling, next-generation sequencing machine in the world and is democratizing DNA sequencing.
“In early January 2012, we started taking orders for our new bench top Ion Proton™ Sequencer, which is designed to sequence the entire human genome in a day for $1,000. Life Technologies has a legacy of democratizing new technologies, and the speed and low cost of semiconductor-based technology will bring DNA sequencing into new areas we can’t even imagine, said Gregory T. Lucier, CEO
• Life Technologies Recognized by Wall Street Journal Technology Innovation Awards
• Fast Company names Life Technologies to its list of the 50 Most Innovative
• TR50 Names Life Technologies Among Top 50 Innovative Companies in 2012
• The Life Technologies Ion 318™ chip was selected as an Innovations 2012 Design and Engineering Awards Honoree
• The Ion Personal Genome Machine won San Diego's CONNECT Most Innovative Product Award in 2011
• Industry Week Names The Life Technologies’ Austin Plant As Best
• The Global 100 – Life Technologies named as "Corporate Knight"
• MIT Technology Review - Top 50 Most Innovative Companies
For the twelfth year, we were able to grow our revenue and earnings per share. Our operating margin expanded to an all-time high of 29.0 percent. Our many achievements in 2011 were driven by innovation and inspired by scientists who continue to shape discovery and improve life. Science never stops, nor does our commitment to innovation and moving science forward. This sense of urgency is what will continue to drive our success in 2012 and beyond.
Upload a collection of supporting files and web addresses to our server to provide more background information to the judges. You may upload any number of attachments and URLs through the "Add Attachments, Videos, or Links to This Entry" link above. (Do NOT list your URLs below.)
Provide a brief (up to 100 words) biography about the nominee or the leader of the nominated organization:
Gregory T. Lucier serves as Chief Executive Officer of Life Technologies and as Chairman of the Company's Board of Directors. Previously, he served as Chairman and Chief Executive Officer of Invitrogen Corporation, which merged with Applied Biosystems in November 2008 to form Life Technologies. The Company is one of the largest providers of systems, biological reagents, and services, supplying scientists around the world in every way that life science technologies are applied.
He received his B.S. in Engineering from Pennsylvania State University and an M.B.A. from Harvard Business School.